NCT04841538

A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: WITHDRAWN

Phase: PHASE1, PHASE2

Sponsor: Elpiscience Biopharma, Ltd.

Condition: Thoracic Tumors, Non-small Cell Lung Cancer, Small Cell Lung Cancer

Signal summary

Status signal: Registry Stop Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: rare_population_signal | strict_eligibility_signal

Stopped reason

Sponsor's clinical development strategy adjustment